Industryweek 7073 Abbvie Buys Drugmaker Shire 54 Billion

AbbVie Buys Drugmaker Shire for $54 Billion

July 18, 2014
Shire Pharmaceuticals has accepted a $54-billion takeover bid from AbbVie in a deal aimed at slashing the U.S. giant's tax bill.

LONDON -- Shire Pharmaceuticals (IW 1000/802) has accepted a $54-billion takeover bid from AbbVie (IW 500/65) (ABBV), the two companies announced Friday, in a deal aimed at slashing the U.S. giant's tax bill.

The takeover, priced with a 53% premium for Shire stock, comes after Ireland-based Shire reversed its opposition to a deal earlier this week.

"The boards of AbbVie and Shire are pleased to announce that they have reached agreement on the terms of a recommended combination of Shire with AbbVie," the two firms said in a statement.

The offer, comprising £24.44 in cash and 0.8960 AbbVie share per Shire share, is the same as the proposal received by the group last Sunday.

The global pharmaceuticals sector has witnessed a stream of multibillion-dollar deals in recent months, as U.S. companies look to Europe as a way to minimize their tax liabilities.

In late May, Anglo-Swedish group AstraZeneca (IW 1000/157) fought off a $117 billion takeover bid from U.S. giant Pfizer (IW 500/25) (PFE) amid worries over British jobs and research capability.

There were also accusations that the tie-up was a cynical ploy by Pfizer to avoid paying tax on profits if they were sent to the United States. The U.S. group had also proposed to switch its tax base to Britain from the U.S.

By Roland Jackson

Copyright Agence France-Presse, 2014

Popular Sponsored Recommendations

How to Build Zero-Cost On-Site Solar and Storage Projects

Nov. 25, 2023
The Inflation Reduction Act offers tax credits, incentives, and financing that enable no-cost projects. In Enel’s eBook, discover the critical role that incentives play in your...

How Digital Twin Technology is Empowering Manufacturers

Sept. 27, 2023
This FAQ delves into why this technology offers business value and considerations toward implementation.

Disruptive EV Technologies Are Driving New Supplier Realities

Sept. 20, 2023
Vehicle electrification is upending the automotive landscape, forcing suppliers to make critical strategic and operational decisions. Understand what that means for you in our...

Digitally Transforming Data and Processes With Product Lifecycle Management

Oct. 29, 2023
Manufacturers face increasing challenges in product development as they strive to consistently deliver improved results. Discover how industry leaders are improving time-to-market...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!